Latest News

NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Is In Phase II Clinical Trials

Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives

Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout

The Invisible Pulse: Connecting the World Where Failure Is Not an Option

Charter Next Generation Appoints Mike Manke as Chief Information Officer

INVESTOR ALERT: Hims & Hers Health, Inc. (NYSE: HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Joint Venture Acquires 186,603-Square-Foot, Single-Tenant Industrial Asset In Windsor, CT

ACRE Releases 2026 Economy of Life Report, Detailing Successful Investment in Nature's Restoration

ROSEN, SKILLED INVESTOR COUNSEL, Encourages AST SpaceMobile, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ASTS

AT&T and Corning Team Up to Engineer the Connected World with Fiber